The bank says it believes interest rate cuts are a “notable tailwind that will likely reignite wider investment interest” in the biotech sector.
Related Posts
Stocks making the biggest moves premarket: UnitedHealth, Morgan Stanley, Target, Southwest & more
These are the stocks posting the largest moves in premarket trading.
Purdue Pharma $7.4 billion opioid settlement wins broad support from U.S. states
The $7.4 billion payment is intended to resolve claims that the drugmaker’s pain medication OxyContin caused a nationwide opioid addiction crisis.
Deutsche Bank names its top UK picks with compounding growth potential — and one has more than 50% upside
The investment bank highlighted stocks with strong growth potential and defensive characteristics in an uncertain market environment.